Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Boehringer Ingelheim Ditches Phase II Alzheimer's Program

  • Post author:Sam
  • Post published:February 8, 2018
  • Post category:BioPharma

Another potential treatment for Alzheimer's disease has been tossed into the rubbish bin. Source: BioSpace

Continue ReadingBoehringer Ingelheim Ditches Phase II Alzheimer's Program

Bioverativ Execs Snagged a Nice Payday After Sanofi Deal

  • Post author:Sam
  • Post published:February 8, 2018
  • Post category:BioPharma

It took more than 8 months and a series of sweetened offers, but Sanofi was able to close their $11.6B deal to buy Bioverativ without triggering an auction. Source: BioSpace

Continue ReadingBioverativ Execs Snagged a Nice Payday After Sanofi Deal

Novartis' Sandoz Jobs on the Chopping Block

  • Post author:Sam
  • Post published:February 8, 2018
  • Post category:BioPharma

The first of the pink slips at Sandoz' generic-drug manufacturing facility in Broomfield, Colo. have been handed out. Source: BioSpace

Continue ReadingNovartis' Sandoz Jobs on the Chopping Block

Madrigal's Cholesterol Drug Succeeds in Mid-Stage Trial

  • Post author:Sam
  • Post published:February 7, 2018
  • Post category:BioPharma

MGL-3196 was well-tolerated with primarily mild and some moderate AEs. Source: BioSpace

Continue ReadingMadrigal's Cholesterol Drug Succeeds in Mid-Stage Trial

Interview Insider: Tips on How to Get Hired at Five Prime Therapeutics

  • Post author:Sam
  • Post published:February 7, 2018
  • Post category:BioPharma

A look at Five Prime, what they do and what they look for in hiring. Source: BioSpace

Continue ReadingInterview Insider: Tips on How to Get Hired at Five Prime Therapeutics

Bay Area's Rani Therapeutics Lands $53M as Company Moves to Clinical Trials

  • Post author:Sam
  • Post published:February 7, 2018
  • Post category:BioPharma

Rani said the latest funding round brings its coffers a total of $142M. Source: BioSpace

Continue ReadingBay Area's Rani Therapeutics Lands $53M as Company Moves to Clinical Trials

Cancer Biotech Novocure Scores New $150M Debt Financing

  • Post author:Sam
  • Post published:February 7, 2018
  • Post category:BioPharma

The cash will be used to to execute core strategies of driving commercial adoption of Optune and advancing the clinical pipeline. Source: BioSpace

Continue ReadingCancer Biotech Novocure Scores New $150M Debt Financing

Teva Continues Restructuring With 46 Cuts in Pennsylvania

  • Post author:Sam
  • Post published:February 7, 2018
  • Post category:BioPharma

The cuts were apparently announced in late January with a WARN notice filed with the state. Source: BioSpace

Continue ReadingTeva Continues Restructuring With 46 Cuts in Pennsylvania

Sanofi Abandons Multiple Mid-Stage Drug Programs

  • Post author:Sam
  • Post published:February 7, 2018
  • Post category:BioPharma

Sanofi is ending a mid-stage program for isatuximab for acute lymphoblastic leukemia, and SAR428926, an anti-LAMP1 ADC for solid tumors. Source: BioSpace

Continue ReadingSanofi Abandons Multiple Mid-Stage Drug Programs

Arbutus Cuts 31% of Global Workforce, to Shutter Its Burnaby Facility

  • Post author:Sam
  • Post published:February 7, 2018
  • Post category:BioPharma

Arbutus said it was undertaking the restructuring in order to better align its hepatitis B business in Warminster, Penn. Source: BioSpace

Continue ReadingArbutus Cuts 31% of Global Workforce, to Shutter Its Burnaby Facility
  • Go to the previous page
  • 1
  • …
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 288
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.